Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Lambert

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Pharmacokinetics and Effects on Saliva Flow of Sublingual and Oral Atropine in Clozapine-Treated and Healthy Adults: An Interventional Cross-Over StudyOmar Mubaslat, Michael Fitzpatrick, Andrew J McLachlan, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
Psychotropic prescribing for acute inpatient admissions in patients with severe psychosisTim Lambert, Deanna L Kelly, Shelda Alcock, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven reviewRébecca Robillard, Naomi L Rogers, Bradley G Whitwell, et al.
BMC Health Services Research|September 28, 2011
The cost associated with administering risperidone long-acting injections in the Australian communityAndrew Dalton, Tim Lambert, Rudolf Schrover, et al.
BMC Psychiatry|March 28, 2012
Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR databaseTim Lambert, Brett Emmerson, Harry Hustig, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|April 18, 2012
An Acute Recovery Unit: the first 18 monthsNick O'Connor, Rachael Mulley, Bianca Grasso, et al.
Journal of Psychiatric Practice|June 30, 2005
Perception of depot antipsychotics by mental health professionalsTim Lambert, Ann Brennan, David Castle, et al.
The Journal of Clinical Psychiatry|May 3, 2008
An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophreniaJohn Lauriello, Tim Lambert, Scott Andersen, et al.
Schizophrenia Research and Treatment|September 1, 2012
Very low-dose risperidone in first-episode psychosis: a safe and effective way to initiate treatmentPatrick D McGorry, John Cocks, Paddy Power, et al.
Biomedicines|January 8, 2025
Discordance Between Triglycerides, Remnant Cholesterol and Systemic Inflammation in Patients with SchizophreniaJeffrey Wang, Maaike Kockx, Gabrielle J Pennings, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Pharmacokinetics and Effects on Saliva Flow of Sublingual and Oral Atropine in Clozapine-Treated and Healthy Adults: An Interventional Cross-Over StudyOmar Mubaslat, Michael Fitzpatrick, Andrew J McLachlan, et al.
Journal of Clinical Psychopharmacology|January 8, 2004
Psychotropic prescribing for acute inpatient admissions in patients with severe psychosisTim Lambert, Deanna L Kelly, Shelda Alcock, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven reviewRébecca Robillard, Naomi L Rogers, Bradley G Whitwell, et al.
BMC Health Services Research|September 28, 2011
The cost associated with administering risperidone long-acting injections in the Australian communityAndrew Dalton, Tim Lambert, Rudolf Schrover, et al.
BMC Psychiatry|March 28, 2012
Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR databaseTim Lambert, Brett Emmerson, Harry Hustig, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|April 18, 2012
An Acute Recovery Unit: the first 18 monthsNick O'Connor, Rachael Mulley, Bianca Grasso, et al.
Journal of Psychiatric Practice|June 30, 2005
Perception of depot antipsychotics by mental health professionalsTim Lambert, Ann Brennan, David Castle, et al.
The Journal of Clinical Psychiatry|May 3, 2008
An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophreniaJohn Lauriello, Tim Lambert, Scott Andersen, et al.
Schizophrenia Research and Treatment|September 1, 2012
Very low-dose risperidone in first-episode psychosis: a safe and effective way to initiate treatmentPatrick D McGorry, John Cocks, Paddy Power, et al.
Biomedicines|January 8, 2025
Discordance Between Triglycerides, Remnant Cholesterol and Systemic Inflammation in Patients with SchizophreniaJeffrey Wang, Maaike Kockx, Gabrielle J Pennings, et al.
Pageof 4